샘플 요청 목록

 카트 문의
시장보고서
상품코드
1765231

세계의 스마트 알약 시장

Smart Pills
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

스마트 알약 세계 시장은 2030년까지 11억 달러에 이를 전망

2024년에 5억 5,050만 달러로 추정되는 스마트 알약 세계 시장은 분석 기간인 2024-2030년 CAGR 11.6%로 성장하여 2030년에는 11억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 식도는 CAGR 12.1%를 나타내고, 분석 기간 종료시에는 2억 3,840만 달러에 이를 전망입니다. 소장 부문의 성장률은 분석 기간에 CAGR 12.5%로 추정됩니다.

미국 시장은 1억 5,150만 달러로 추정, 중국은 CAGR 10.8%로 성장 예측

미국의 스마트 알약 시장은 2024년에 1억 5,150만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR 10.8%로 2030년에는 1억 6,300만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 10.2%와 9.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.4%를 보일 전망입니다.

세계의 스마트 알약 시장 - 주요 동향과 촉진요인 정리

스마트 알약이란 무엇이며, 헬스케어에 어떤 혁명을 가져올 것인가?

센서, 카메라, 통신 모듈이 탑재된 스마트 알약은 복약 순응도, 생리적 매개변수, 위장 상태에 대한 실시간 데이터를 제공함으로써 헬스케어에 혁명을 일으키고 있습니다. 이러한 섭취형 디바이스는 진단, 모니터링, 약물 전달 목적으로 점점 더 많이 사용되고 있으며, 기존의 진단 및 치료 방법에 대한 비침습적 대안을 제공합니다. 스마트 알약은 의료 서비스 제공업체가 환자의 건강 상태를 원격으로 모니터링하고 데이터에 기반한 치료 조정을 결정할 수 있도록 함으로써 개인 맞춤형 의료를 가능하게 합니다. 또한, 특히 당뇨병, 심혈관 질환, 정신 질환과 같은 만성 질환에서 환자의 복약 순응도를 향상시키고 있습니다.

스마트 알약 시장을 주도하는 부문은?

식도, 소장, 대장, 위 등이 대상. 센서가 장착된 스마트 알약은 모니터링 및 진단에 광범위하게 사용되기 때문에 선두를 달리고 있습니다. 용도는 캡슐 내시경, 환자 모니터링, 약물 전달로 분류되며, 캡슐 내시경은 소화관 진단에서 채택이 확대되면서 시장을 주도하고 있습니다. 최종 사용자는 병원, 클리닉, 연구기관, 재택의료 등 다양하지만, 병원 및 클리닉이 가장 큰 시장 점유율을 차지하고 있는데, 이는 고급 진단 및 개인화된 치료 계획에서 스마트 알약의 사용이 증가하고 있기 때문입니다.

스마트 알약스의 미래를 좌우할 트렌드는 무엇일까?

스마트 알약 시장은 센서 기술의 발전, 소형화, 데이터 분석 등 몇 가지 트렌드에 의해 형성되고 있으며, AI와 머신러닝의 통합으로 스마트 알약은 보다 정확하고 예측 가능한 건강 통찰력을 제공함으로써 진단 및 치료 가능성을 높이고 있습니다. 디지털 헬스 및 원격 의료에 대한 관심이 높아지면서 원격 모니터링 및 실시간 데이터 전송을 제공하는 스마트 알약에 대한 수요가 증가하고 있습니다. 또한, 개인 맞춤형 의료 트렌드는 표적화된 약물 전달 및 피드백 메커니즘을 갖춘 스마트 알약의 개발에 박차를 가하고 있습니다. 제약회사와 하이테크 기업의 협업은 스마트 알약 기술의 혁신을 더욱 가속화하고 있습니다.

스마트 알약 시장의 성장을 가속하는 요인은 무엇인가?

스마트 알약 시장의 성장은 원격 환자 모니터링 및 디지털 건강 솔루션에 대한 수요 증가, 센서 및 소형화 기술의 발전, 개인 맞춤형 의료 및 표적 약물 전달에 대한 관심 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 또한, 노인 인구 증가와 만성 질환의 확산, 원격 의료 및 디지털 치료법의 확대, 제약 회사와 기술 회사의 협력 관계 증가도 시장 성장에 기여하고 있습니다. 또한, 비용 효율적이고 사용자 친화적인 스마트 알약 솔루션의 개발, 지원적인 규제 프레임워크, 디지털 헬스 기술에 대한 투자 확대로 인해 시장이 발전하고 있습니다.

부문

용도(캡슐 내시경, 약물전달, 환자 모니터링);최종 용도(병원, 진단센터, 연구기관);대상 영역(식도, 소장, 대장, 위)

조사 대상 기업 예

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology(Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 도메인 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.07.16

Global Smart Pills Market to Reach US$1.1 Billion by 2030

The global market for Smart Pills estimated at US$550.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Esophagus, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$238.4 Million by the end of the analysis period. Growth in the Small Intestine segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$151.5 Million While China is Forecast to Grow at 10.8% CAGR

The Smart Pills market in the U.S. is estimated at US$151.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$163.0 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Smart Pills Market - Key Trends and Drivers Summarized

What Are Smart Pills and How Are They Revolutionizing Healthcare?

Smart pills, equipped with sensors, cameras, and communication modules, are revolutionizing healthcare by providing real-time data on medication adherence, physiological parameters, and gastrointestinal conditions. These ingestible devices are increasingly being used for diagnostic, monitoring, and drug delivery purposes, offering a non-invasive alternative to traditional diagnostic and therapeutic methods. Smart pills are enabling personalized medicine by allowing healthcare providers to monitor patient health remotely and make data-driven decisions for treatment adjustments. They are also improving patient compliance with medication regimens, particularly for chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions.

Which Segments Are Leading in the Smart Pills Market?

Target Areas include esophagus, small intestine, large intestine, and stomach. Sensor-enabled smart pills lead due to their extensive use in monitoring and diagnostics. Applications are categorized into capsule endoscopy, patient monitoring, and drug delivery, with capsule endoscopy dominating the market owing to its growing adoption in gastrointestinal diagnostics. End-users range from hospitals and clinics to research institutions and home care settings, with hospitals and clinics holding the largest market share due to the increasing use of smart pills in advanced diagnostics and personalized treatment plans.

What Trends Are Shaping the Future of Smart Pills?

The smart pills market is being shaped by several trends, including advancements in sensor technologies, miniaturization, and data analytics. The integration of AI and machine learning is enabling smart pills to provide more accurate and predictive health insights, enhancing their diagnostic and therapeutic potential. The rising focus on digital health and telemedicine is driving the demand for smart pills that offer remote monitoring and real-time data transmission. Additionally, the trend towards personalized medicine is spurring the development of smart pills with targeted drug delivery and feedback mechanisms. Collaborations between pharmaceutical companies and tech firms are further accelerating innovation in smart pill technologies.

What Factors Are Driving Growth in the Smart Pills Market?

The growth in the smart pills market is driven by several factors, including the increasing demand for remote patient monitoring and digital health solutions, advancements in sensor and miniaturization technologies, and the rising focus on personalized medicine and targeted drug delivery. The growth in the geriatric population and the prevalence of chronic diseases, the expansion of telemedicine and digital therapeutics, and the increasing collaborations between pharmaceutical and technology companies are also contributing to market growth. Furthermore, the development of cost-effective and user-friendly smart pill solutions, supportive regulatory frameworks, and growing investments in digital health technologies are propelling the market forward.

SCOPE OF STUDY:

The report analyzes the Smart Pills market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring); End-Use (Hospital, Diagnostic Center, Research Institute); Target Area (Esophagus, Small Intestine, Large Intestine, Stomach)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Smart Pills - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Remote Patient Monitoring and Healthcare Automation Drives Market Growth
    • Advancements in Sensor Technologies and Miniaturization Propel Smart Pills Market Expansion
    • Rising Demand for Personalized Medicine Strengthens Business Case for Smart Pills
    • Growth in Geriatric Population and Chronic Disease Management Spurs Adoption
    • Development of Smart Pills with Real-Time Data Transmission and Feedback Enhances Market Competitiveness
    • Integration with AI and Big Data Analytics in Healthcare Expands Addressable Market Opportunity
    • Emergence of Smart Pills with Ingestible Sensors for Drug Delivery and Diagnostics Generates New Opportunities
    • Rising Interest in Digital Health and Telemedicine Solutions Supports Market Growth
    • Focus on Enhancing Patient Adherence and Treatment Outcomes Propels Demand for Smart Pills
    • Growing Applications in Clinical Trials and Therapeutic Monitoring Accelerate Market Adoption
    • Development of User-Friendly, Patient-Centric Smart Pills Supports Market Differentiation
    • Need for Integration with Broader Digital Health Ecosystems Drives Market Evolution
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Pills Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Esophagus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Esophagus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Small Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Small Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Large Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Capsule Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Capsule Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Diagnostic Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • JAPAN
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CHINA
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • EUROPE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • FRANCE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • GERMANY
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제